GlassScriptPhysician profile
Mary E Jaeger
NPI 1891129425
$1,136.91
in general payments reported to CMS, 2019-2025
11 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Clinical Nurse Specialist provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.96 · 2022: $181 · 2023: $366 · 2024: $280 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $385.51 | 2023-2025 | Cygnus Dual, Puraply, Simplimax |
| Smith+Nephew, INC. | $127.14 | 2022-2023 | Regranex |
| Kci USA, INC. | $125.00 | 2023 | Prevena |
| Solventum Corporation | $112.19 | 2024 | V.A.C. Dermatac, Activ.A.C., Promogran Prisma |
| Hydrofera LLC | $106.89 | 2023 | Cutimed Sorbact |
| Urgo Medical North America, LLC | $80.08 | 2024-2025 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Medline Industries LP | $75.61 | 2022 | |
| Reprise Biomedical, INC. | $54.73 | 2024 | Miro3d |
| Paratek Pharmaceuticals, INC. | $30.59 | 2025 | Nuzyra |
| Hartmann USA, INC. | $24.21 | 2025 | Zetuvit Plus 10x10 P10 |
| Biohaven Pharmaceuticals, INC. | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Jaeger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.